Viewing nowGlymax Tablet 4 mg (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Ixu Pharmaceutical Co., Ltd.

MFDS item code 201901114 · Approved 2019.02.22 · Insurance code 658502090
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to effectively control blood sugar levels in patients with type 2 diabetes. It is administered as an adjunct to dietary and exercise therapy, and in cases where blood sugar control is inadequate, it may be used alone or in combination with other oral hypoglycemic agents or insulin. In particular, when it is difficult to control blood sugar solely with sulfonylureas or metformin, this medication is administered together with metformin. The combination is flexibly adjusted based on the patient's blood sugar management status to improve blood sugar control.
Adjust the dose individually for each patient. Swallow without chewing, with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination In patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start at 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previous medicine. 4) Dose adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by consuming sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even after initially successful management. Therefore, patients should be observed carefully. Severe hypoglycemia requires immediate medical attention and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy with metformin and other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered concomitantly with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication is not used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Moreover, it should not be administered in cases of allergy to this medication or to sulfonylureas or sulfonamides. There is no experience with use in patients with severe liver or kidney dysfunction; therefore, in such cases, switching to insulin therapy is advisable. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication. In patients with severe infections, before and after surgery, or those with severe trauma, insulin therapy is recommended. Patients with gastrointestinal disturbances such as diarrhea or vomiting may not absorb food properly, increasing the risk of hypoglycemia, so caution is warranted. This medication contains lactose and should not be given to patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. At the start of therapy, there is a higher risk of hypoglycemia; thus, especially elderly patients, those with poor nutritional status, irregular meals, and those who consume alcohol frequently should monitor their blood sugar closely. Patients with poor kidney or liver function, those with endocrine disorders, and those taking other medications may also have an increased risk of hypoglycemia and should be cautious. This medication can induce hypoglycemia, with symptoms such as headache, extreme hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and decreased consciousness. If hypoglycemia is severe, it may lead to loss of consciousness or coma, so immediate treatment is required when symptoms appear. Transient visual disturbances, gastrointestinal disturbances, liver function abnormalities, blood abnormalities, and allergic reactions may occur infrequently, and if abnormal symptoms appear, you should consult a doctor. It is important to have regular meals, exercise, and manage weight while taking this medication, and it is advisable to always have foods containing sugar prepared to prevent hypoglycemic symptoms. When receiving treatment from other doctors or pharmacists, you must inform them that you are currently taking this medication, and in situations of stress such as surgery or infection, insulin therapy may need to be switched. After taking the medication, regular monitoring of blood sugar and urine tests should be conducted to check the drug's effectiveness and side effects. This medication can affect driving or operating machinery; therefore, caution is necessary when hypoglycemic symptoms are present. Since this medication is metabolized in the liver, caution must be exercised when taken with other medications that affect liver function, as some drugs may increase or decrease the blood sugar-lowering effect of this medication. Women who are pregnant or breastfeeding should not take this medication and should switch to insulin therapy if necessary. The safety and efficacy in pediatric patients have not been established, so it is not to be used in those under 18 years of age. Elderly patients may need dose adjustments due to delayed drug excretion from declining kidney function. In the case of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment, and measures such as inducing vomiting, gastric lavage, or glucose injection may be necessary. Keep the medication out of the reach of children and store it in its original container.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, partial paralysis, altered perception, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, skin and mucous membrane syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best to store it at room temperature between 1 and 30 degrees Celsius.
Light blue rectangular tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Ixu Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.